[Vasopressin and angiogenesis].
In adult mammals, the CNS vasculature remains essentially quiescent, excepted for specific pathologies. In the seventies, it was reported that proliferation of astrocytes and endothelial cells occurs within the hypothalamic magnocellular nuclei when strong metabolic activation of the vasopressinergic and oxytocinergic neurons was induced by prolonged hyperosmotic stimulation. Using more appropriate techniques, we first demonstrated that in these nuclei, the proliferative response to osmotic stimulus is essentially associated with local angiogenesis. We then showed that hypothalamic magnocellular neurons express vascular endothelial growth factor (VEGF), a potent angiogenic factor, that plays a major rôle in the angiogenesis induced by osmotic stimuli. We then demonstrated a correlation between increased VEGF secretion and local hypoxia. In AVP-deficient Brattleboro rats, the dramatic activation of magnocellular hypothalamic neurons failed to induce hypoxia, VEGF expression or angiogenesis suggesting a major role of hypothalamic AVP. Lastly we showed that 1) hypoxia and angiogenesis were not observed in non-osmotically stimulated Wistar rats in which circulating AVP was increased by the prolonged infusion of exogenous AVP, 2) contractile arterioles afferent to the magnocellular nuclei were strongly constricted by the perivascular application of AVP via V1a receptors (V1a-R) stimulation, and 3) following the intracerebral administration of selective V1a-R antagonist to osmotically stimulated rats, hypothalamic hypoxia and angiogenesis were inhibited. Together, these data strongly suggest that the angiogenesis induced by osmotic stimulation relates to tissue hypoxia resulting from the constriction of local arterioles, via the stimulation of perivascular V1a-R by AVP locally released from dendrites.
UMR CNRS 5203, Institut de Génomique Fonctionnelle, 34000 Montpellier, France.
Gérard
G
Alonso
D000818:Animals; D001127:Arginine Vasopressin / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D001160:Arterioles / Q000378:metabolism; D001253:Astrocytes / Q000166:cytology; D015687:Cell Hypoxia; D002536:Cerebral Arteries / Q000378:metabolism; D003712:Dendrites / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology; D007031:Hypothalamus / Q000166:cytology / Q000502:physiology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D011910:Rats, Brattleboro; D017208:Rats, Wistar; D017483:Receptors, Vasopressin / Q000187:drug effects / Q000502:physiology; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage / Q000494:pharmacology; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis / Q000235:genetics; D014661:Vasoconstriction / Q000502:physiology
D017483:Receptors, Vasopressin; D012462:Saline Solution, Hypertonic; D042461:Vascular Endothelial Growth Factor A; C467498:vascular endothelial growth factor A, rat; D001127:Arginine Vasopressin